Lv1
40 积分 2023-02-06 加入
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
1个月前
已完结
Innovative practices in the diagnosis and treatment of peritoneal surface malignancies: insights from the 15th congress of the Peritoneal Surface Oncology Group International (PSOGI)
1个月前
已完结
Innovative practices in the diagnosis and treatment of peritoneal surface malignancies: insights from the 15th congress of the Peritoneal Surface Oncology Group International (PSOGI)
1个月前
已关闭
Mucin O-Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Review
3个月前
已完结
Mucin O-Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Review
5个月前
已关闭
Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei
7个月前
已完结
Mucins in cancer: protection and control of the cell surface
7个月前
已完结
An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape
8个月前
已完结
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model
11个月前
已完结
Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway
11个月前
已完结
皖公网安备34019202002308
